Elevations in T-helper-2-initiating cytokines (interleukin-33, interleukin-25 and thymic stromal lymphopoietin) in lesional skin from chronic spontaneous ('idiopathic') urticaria
Summary Background The mechanism of wealing in chronic spontaneous urticaria (CSU) is largely unknown. We previously demonstrated increased expression of T‐helper 2 [interleukin (IL)‐4 and IL‐5] cytokines in skin biopsies from CSU. This suggested that Th2‐initiating cytokines [IL‐33, IL‐25 and thymi...
Saved in:
Published in | British journal of dermatology (1951) Vol. 172; no. 5; pp. 1294 - 1302 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.05.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Summary
Background
The mechanism of wealing in chronic spontaneous urticaria (CSU) is largely unknown. We previously demonstrated increased expression of T‐helper 2 [interleukin (IL)‐4 and IL‐5] cytokines in skin biopsies from CSU. This suggested that Th2‐initiating cytokines [IL‐33, IL‐25 and thymic stromal lymphopoietin (TSLP)], released through innate immune mechanisms, may play a role in pathogenesis.
Objectives
To identify Th2‐initiating cytokines in lesional and nonlesional skin from patients with CSU and to compare the results with a control group.
Methods
Paired biopsies (one from a 4–8 h spontaneous weal and one from uninvolved skin) were taken from eight patients with CSU and nine control subjects, and studied by immunohistochemistry and confocal microscopy.
Results
There were increases in IL‐4+ and IL‐5+ cells in lesional skin vs. controls (P = 0·03 and P < 0·001, respectively) and marked elevations in the numbers of IL‐33+, IL‐25+ and TSLP+ cells in the dermis of lesional skin vs. both nonlesional skin (P = 0·002, P = 0·01 and P = 0·04, respectively) and controls (P = 0·001, P < 0·001 and P = 0·005, respectively). There was also a correlation between the numbers of IL‐33+ and IL‐25+ cells (r = 0·808, P = 0·015). IL‐33 localized to CD31+ endothelial cells, CD90+ fibroblasts, CD68+ macrophages and tryptase+ mast cells, whereas IL‐25 was expressed by epithelial cells, mast cells and major basic protein‐positive eosinophils. IL‐33 and IL‐25 were constitutively expressed in the epidermis of both controls and patients with CSU.
Conclusions
Increased expression of Th2‐initiating cytokines in lesional skin in CSU suggests that innate pathways might play a role in the mechanism of wealing. As Th2‐initiating cytokines play a role in mast cell activation, inflammation and vascular leakage in CSU, these findings may also have therapeutic implications.
What's already known about this topic?
Increased expression of T‐helper (Th)2 [interleukin (IL)‐4 and IL‐5] cytokines was previously demonstrated in skin biopsies from chronic spontaneous urticaria (CSU).
What does this study add?
The Th2‐initiating cytokines (IL‐33, IL‐25 and thymic stromal lymphopoietin) are also expressed in CSU, but in lesional, not unaffected, skin.
This suggests that innate pathways may play a role in the mechanism of wealing.
IL‐33 colocalized to endothelial cells, fibroblasts, macrophages and mast cells; IL‐25 was expressed by epithelial cells, mast cells and eosinophils. |
---|---|
Bibliography: | ark:/67375/WNG-ML6RTFKX-Z Fig S1. Examples of regions of interest. Image analysis of the epidermis is shown with adjacent tables of the area and average fluorescence intensity. The interleukin (IL)-33 example is lesional skin, and the IL-25 is control skin.Fig S2. Confocal microscopy of interleukin (IL)-33 (red) and IL-25 (red) staining in the stratum basale, spinosum and granulosum of the epidermis from control, nonlesional and lesional skin from chronic spontaneous urticaria.Fig S3. Interleukin (IL)-33 and IL-25 measurements in the stratum basale, spinosum and granulosum of the epidermis from control, nonlesional and lesional skin from chronic spontaneous urticaria.Data S1. Supplementary methods, results and discussion. ArticleID:BJD13621 istex:90FF7653B59396C505FAB8E56FCF1E1F4630C425 Imperial College Trust Imperial College and King's College School of Medicine MRC-Asthma U.K. Centre in Allergic Mechanisms in Asthma Conflicts of interest Funding sources This work was supported by the Imperial College Trust and the MRC‐Asthma U.K. Centre in Allergic Mechanisms in Asthma, Imperial College and King's College School of Medicine, London, U.K. None declared. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0007-0963 1365-2133 1365-2133 |
DOI: | 10.1111/bjd.13621 |